Publications by authors named "Maiwand Farouq"
Background: Studies have shown that the risk of new-onset heart failure (HF) is higher postimplantation for patients receiving right ventricular pacing.
Objective: This study aimed to investigate incidence, risk factors, and implications for long-term prognosis of new-onset HF in patients after pacemaker implantation.
Methods: Patients without pre-existing HF who received a pacemaker in Sweden during the period of 2005 to 2020 were identified via the nationwide Pacemaker Registry.
Article Synopsis
- Patients with heart failure (HF) and bradycardia may receive different types of cardiac implantable electronic devices (CIED) based on various factors like age and comorbidities, and the study aimed to evaluate their 5-year outcomes post-implantation.
- The study included 37,745 HF patients in Sweden who received CIEDs from 2005 to 2018 and found significant differences in demographics and outcomes between those receiving implantable cardioverter defibrillators and pacemakers.
- Results indicated higher mortality rates among single-chamber pacemaker recipients (61%) compared to the average (40%), while cardiovascular mortality was highest in cardiac resynchronization therapy recipients, highlighting how device selection correlates with patient
Background: Patients with chronic right ventricular (RV) pacing are at an increased risk of heart failure. Previous studies have indicated that cardiac resynchronization therapy (CRT) is underused in this setting, and that there may be sex-based differences in both CRT use and clinical outcome.
Objective: To evaluate sex-based differences in CRT use and clinical outcome for patients with new-onset heart failure post RV pacing.
Article Synopsis
- The study aimed to assess the effects of age on mortality rates in patients with nonischemic cardiomyopathy treated with either CRT-D or CRT-P devices.
- The research included over 4,000 patients in Sweden from 2005 to 2020 and found that CRT-D treatment was linked with significantly lower overall mortality compared to CRT-P, especially in younger patients under 60.
- The findings highlight that while CRT-D improves 5-year survival rates, the age-related benefits vary, with younger patients experiencing the most noticeable reduction in mortality.
Background: Left ventricular (LV) lead position may be an important factor for delivering effective cardiac resynchronization therapy (CRT). We therefore aimed to evaluate the effects of LV lead position, stratified by native QRS morphology, regarding the clinical outcome.
Methods: A total of 1295 CRT-implanted patients were retrospectively evaluated.
Background: Observational data suggest that an anterior or apical left ventricular (LV) position in cardiac resynchronization therapy (CRT) is associated with worse outcome and higher likelihood of "nonresponse." It is not known whether the benefits of optimizing LV lead position in a second procedure outweighs the procedural risks.
Objective: To evaluate the clinical effects of LV lead repositioning.
. This study assessed the management approach and outcome of the pacemaker or implantable cardioverter-defibrillator (ICD) leads malpositioned in the left heart. Malpositioned leads (MPLs) may have deleterious consequences, and appropriate management remains uncertain.
View Article and Find Full Text PDFMalpositioned pacemaker lead in the left ventricle (LV) is a rare procedural complication, which causes a special risk of thromboembolic events. Hence, prompt identification and early management of misplaced leads inside the LV is critical. Herein, we present a case of malpositioned pacemaker lead with transient ischemic attacks after the pacemaker implantation.
View Article and Find Full Text PDF